Atara Biotherapeutics atarabio.com


Public list: Smart Money VCs (6327) Pharma Startups (4523)

Atara Biotherapeutics is a privately-held drug development company with a focus on innovative therapies for patients with debilitating diseases. The research of Atara and its family of companies is based on groundbreaking discoveries regarding the ability of activin, myostatin and other biological targets to change the course of disease progression. Atara has three novel biologics in development, including PINTA 745 (Phase 2) for protein energy wasting in end-stage renal disease, STM 434 (IND-r...Show all

Atara Biotherapeutics is a privately-held drug development company with a focus on innovative therapies for patients with debilitating diseases. The research of Atara and its family of companies is based on groundbreaking discoveries regarding the ab...Show all

Company (IPO / Went public)

Phone: 805-309-0888

Fax:

2659 Townsgate Road
Suite 236
Thousand Oaks, 91361
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Atara Biotherapeutics $127M Oct 16, 2014

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Atara Biotherapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 9 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Variant activin receptor polypeptides and uses thereof Dec 19, 2011 Aug 06, 2013 Patent
Stabilized activin iib receptor polypeptides and uses thereof Nov 25, 2009 Apr 02, 2013 Patent